Trial
NCT03402880
ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
City of Hope Medical Center
Collaborators
Addario Lung Cancer Medical Institute
Condition
Extensive Stage Small Cell Lung Carcinoma
Intervention
Pembrolizumab
Why stopped
No patients enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-29